Theorem Clinical Research

Drug Sponsors

Cellular Biomedicine Group acquires Agreen Biotech

Wednesday, August 13, 2014 01:01 PM

Cellular Biomedicine Group, a California-based developer of new treatments for degenerative and cancerous diseases, has acquired China-based Agreen Biotech and its founder’s U.S. patent for $3.28 million in cash, the issuance of 753,522 shares of CBMG common stock and the issuance of 75,000 shares of CBMG restricted stock units.

More... »


Oncothyreon acquires Alpine Biosciences

Wednesday, August 13, 2014 12:59 PM

Oncothyreon, a Washington-based biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer, has acquired Alpine Biosciences, a Seattle, Wash.-based privately held biotechnology company developing protocells, a nanoparticle platform technology designed to enable the targeted delivery of multiple therapeutic agents, including nucleic acids, proteins, peptides and small molecules. 

More... »


Galenica lays foundation for two listed, independent companies

Wednesday, August 13, 2014 12:57 PM

The Galenica Group, a Switzerland-based healthcare group that develops, manufactures and markets pharmaceutical products, runs pharmacies, provides logistical and database services and sets up networks, plans to separate into two independent companies.

More... »

Marathon Pharmaceuticals opens bioscience center in Chicago

Thursday, August 7, 2014 09:00 AM

Marathon Pharmaceuticals has opened the Marathon Bioscience Center in Chicago. The facility houses the company’s research, clinical and regulatory staff, who develop and register new treatments for rare diseases.

More... »

Alvogen acquires Korean Dream Pharma for $187 million

Thursday, August 7, 2014 08:00 AM

Alvogen, an international, privately owned pharmaceuticals company, has acquired Dream Pharma of South Korea for $187 million in cash. Dream will be acquired through Alvogen’s Asian subsidiaries and, on completion, the combination will create one of the largest generic pharmaceutical companies in South Korea.

More... »

Telik completes merger with MabVax Therapeutics

Tuesday, August 5, 2014 10:00 AM

MabVax Therapeutics, a privately held cancer immunotherapy company, and Telik, a clinical stage oncology drug development company, have merged. MabVax became a wholly owned subsidiary of Telik effective July 8, following Telik stockholder approval at Telik's annual meeting of stockholders July 7.

More... »

Roche to acquire Santaris Pharma for $450M

Monday, August 4, 2014 02:14 PM

Roche has agreed to acquire Santaris Pharma, a privately held biopharmaceutical company based near Copenhagen, Denmark. Santaris Pharma has pioneered its proprietary Locked Nucleic Acid (LNA) platform that has contributed to an emerging era of RNA-targeting therapeutics. This new class of medicines has the potential to address difficult to treat diseases in a range of therapeutic areas.

More... »

Pfizer, Roche join ADDPLAN DF Consortium

Monday, August 4, 2014 02:12 PM

Pfizer and Roche have joined the ADDPLAN DF Consortium. The consortium was founded in 2013 by Novartis, Janssen PharmaceuticalsEli Lilly and Aptiv Solutions, an Icon company, to lead the design and implementation of adaptive trials. The goal of the ADDPLAN DF Consortium is to develop methodologies and execution technologies that improve dose-selection, which remains a major barrier to resolving high failure rates in phase III trials.

More... »

Allergan files federal lawsuit against Valeant, Pershing Square

Monday, August 4, 2014 02:10 PM

Allergan has filed a lawsuit against Valeant Pharmaceuticals InternationalPershing Square Capital Management and its principal, William A. Ackman, alleging that Valeant, Pershing Square and Ackman violated federal securities laws prohibiting insider trading, engaged in other fraudulent practices and failed to disclose legally required information.

More... »

BioElectronics president outlines four-part growth strategy

Monday, August 4, 2014 02:09 PM

In a letter to shareholders, Andrew J. Whelan, president of BioElectronics, emphasized a four-part growth strategy initiated in the last year. 

More... »

Subscribe to The CenterWatch Monthly
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

October 27

NIH’s I-Corps boot camp aims to transform researchers into better businesspeople before they launch products

Covance, Frenova form partnership to share patient databases, find effective treatments for renal disease

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

CROs driving changes in patient recruitment
Data- and tech-aided enrollment services a competitive advantage

Trials with in-home nurses poised to grow
Higher expense, but may improve recruitment and retention for select trials

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Today's fastest, most economical sponsors
Standout sponsors reveal how they shorten regulatory, clinical cycle times

From the trenches: Sites' eye view of state of the industry
CW’s first site focus groups uncover frustration with 'progress,' but a passion for their mission

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs